Login to Your Account



Financings Roundup


Thursday, February 28, 2013

• Hyperion Therapeutics Inc., of South San Francisco, said it is offering up to $50 million of shares of common stock, though the number of shares and share price have not yet been disclosed. Underwriters Leerink Swann, Cowen and Co., Needham & Co. and JMP Securities will have an option to purchase an additional $7.5 million in stock to cover overallotments.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription